Tomasz H. Zastawny
Corporate Officer/Principal presso Quark Ventures, Inc.
Profilo
Tomasz H.
Zastawny is the founder of ECRC LLC, which was founded in 2008.
He is currently a Partner at Quark Ventures, Inc. since 2015.
Dr. Zastawny's former positions include Chief Development Officer at Adial Pharmaceuticals, Inc., VP-Drug Development & Clinical Operations at AVEO Pharmaceuticals, Inc., Vice President-Drug Development at Amrita Therapeutics Ltd.
from 2015 to 2016, Vice President-R&D at Boston Therapeutics, Inc. from 2012 to 2015, and President-Central & Eastern European Unit at PRA International LLC.
Dr. Zastawny holds a doctorate degree from the University of Nicolaus Copernicus and the Polish Academy of Sciences.
Posizioni attive di Tomasz H. Zastawny
| Società | Posizione | Inizio |
|---|---|---|
| Quark Ventures, Inc. | Corporate Officer/Principal | 01/08/2015 |
Precedenti posizioni note di Tomasz H. Zastawny
| Società | Posizione | Fine |
|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 |
Amrita Therapeutics Ltd.
 Amrita Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amrita Therapeutics Ltd. develops and commercializes novel drugs for health diseases. The firm engages in dual program of research on both novel peptide-based therapies and development of hybrid therapeutic devices to provide in situ cancer therapy. The company was founded by Ananda M. Chakrabarty and Susan Kling Finston in 2008 and is headquartered in Ahmedabad, India. | Corporate Officer/Principal | 01/09/2016 |
| NANOMIX CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/05/2015 |
PRA International LLC
 PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The company is based in Raleigh, NC. | Corporate Officer/Principal | - |
ECRC LLC
 ECRC LLC Pharmaceuticals: MajorHealth Technology ECRC LLC manufactures pharmaceutical products. The private company is based in Edmond. The American company was founded by Tomasz H. Zastawny. | Amministratore Delegato | - |
Formazione di Tomasz H. Zastawny
| University of Nicolaus Copernicus | Doctorate Degree |
| Polish Academy of Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ADIAL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
ECRC LLC
ECRC LLC Pharmaceuticals: MajorHealth Technology ECRC LLC manufactures pharmaceutical products. The private company is based in Edmond. The American company was founded by Tomasz H. Zastawny. | Health Technology |
| Quark Ventures, Inc. | |
Amrita Therapeutics Ltd.
Amrita Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amrita Therapeutics Ltd. develops and commercializes novel drugs for health diseases. The firm engages in dual program of research on both novel peptide-based therapies and development of hybrid therapeutic devices to provide in situ cancer therapy. The company was founded by Ananda M. Chakrabarty and Susan Kling Finston in 2008 and is headquartered in Ahmedabad, India. | Health Technology |
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
PRA International LLC
PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The company is based in Raleigh, NC. | Health Technology |
- Borsa valori
- Insiders
- Tomasz H. Zastawny
